ANCA Small-Vessel Vasculitis

Journal of the American Society of Nephrology

Volumn 8, Issue 2, 1997, Pages 306-322

  Falk, Ronald J ^a   Jennette, J Charles ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

FEMALE; GLOMERULONEPHRITIS; HUMAN; IMMUNOLOGY; KIDNEY; KIDNEY DISEASE; LUNG; MALE; METABOLISM; NOMENCLATURE; PATHOLOGY; PROGNOSIS; REVIEW; SKIN; SYNDROME; VASCULARIZATION; VASCULITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY; KIDNEY DISEASES; LUNG; MALE; PROGNOSIS; SKIN; SYNDROME; TERMINOLOGY; VASCULITIS;

EID: 0031065783     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, McCluskey RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A: Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum 37: 187-192, 1994.
2. Jennette JC, Falk RJ: The pathology of vasculitis involving the kidney. Am J Kidney Dis 24: 130-141, 1994.
3. Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318: 1651-1657, 1988.
4. Hagen EC, Ballieux Be, van Es LA, Daha MR, van der Woude FJ: Antineutrophil cytoplasmic autoantibodies: A review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. Blood 81: 1996-2002, 1993.
5. Jennette JC, Wilkman AS, Falk RJ: Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135: 921-930, 1989.
6. Jennette JC, Wilkman AS, Tuttle RH, Falk RJ: How pauci-immune is ANCA-associated crescentic glomerulonephritis (CGN)? [Abstract] J Am Soc Nephrol 7: 1735, 1996.
7. Short AK, Esnault VL, Lockwood CM: Anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane antibodies: Two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis 26: 439-445, 1995.
8. Fienberg R, Mark EJ, Goodman M, McCluskey RT, Niles JL: Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis. Hum Pathol 24: 160-168, 1993.
9. Gaudin PB, Askin FB, Falk RJ, Jennette JC: The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic antibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 104: 7-16, 1995.
10. Falk RJ, Hogan S, Carey TS, Jennette JC: Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulo-nephritis and systemic vasculitis: The Glomerular Disease Collaborative Network. Ann Intern Med 113: 656-663, 1990.
11. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ, and the Glomerular Disease Collaborative Network: Prognostic markers in patients with ANCA-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7: 23-32, 1996.
12. Nachman PH, Hogan SL, Jennette JC, Falk RJ: Treatment response and relapse in ANCA-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7: 23-32, 1996.
13. Niles JL, Pan G, Collins AB, Shannon T, Skates S, Fienberg R, Arnaout MA, McCluskey RT : Value of antigen-specific radio-immunoassays for measuring anti-neutrophil cytoplasmic antibodies (ANCA) in the differential diagnosis of rapidly progressive glomerulonephritis. J Am Soc Nephrol 2: 27-36, 191.
14. Niles JL: A renal biopsy is essential for the management of ANCA-positive patients with glomerulonephritis: The Contr View. Sarcoidosis Vasculitis and Diffuse Lung Diseases 13: 232-234, 1995.
15. Bosch X, Lopez-Soto A, Mirapiex E: Antineutrophil cytoplasmic autoantibody-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage. Arch Pathol Lab Med 118: 517-518, 1994.
16. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS: Wegener's granulomatosis: An analysis of 158 patients. Ann Intern Med 116: 488-498, 1992.
17. Andrassy K, Rasmussen N: Treatment of granulomatous disorders of the nose and paranasal sinuses. Rhinology 27: 221-230, 1989.
18. Jennette JC, Milling DM, Falk RJ: Vasculitis affecting the skin: A review [Editorial]. Arch Dermatol 130: 899-906, 1994.
19. Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM: Microscopic polyarteritis: Presentation, pathology and prognosis. Q J Med 56: 467-483, 1985.
20. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM: Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 40: 757-763, 1991.
21. Fauci AS, Katz P, Haynes BF, Wolff SM: Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med 301: 235-238, 1979.
22. Tarlar-Williams C, Hijazi Y, Walther M, Linehan WM, Hallahan CW, Lubensky I, Kerr GS, Hoffman GS, Fauci AS, Sneller MC: Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener's granulomatosis. Ann Intern Med 124: 477-484, 1996.
23. Gaskin G, Savage CO, Ryan JJ, Jones S, Rees AJ, Lockwood CM, Pusey CD: Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 6: 689-694, 1991.
24. DeRemee RA, McDonald TJ, Weiland LH: Wegener's granulomatosis: Observations on treatment with antimicrobial agents. Mayo Clin Proc 60: 27-32, 1985.
25. Stegemann CA, Cohen-Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM: Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis. Ann Intern Med 120: 12-17, 1994.
26. Reinhold-Keller E, De Groot K, Rudert H, Nölle B, Heller M, Gross WL: Response to trimethoprin-sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease. Q J Med 89: 15-23, 1996.
27. Stegman CA, Cohen Tervaert JW, de Jong PE, Kallenberg CGM: Trimethoprin-sulfamethoxazole for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 335: 16-20, 1996.
28. De Groot K, Reinhold-Keller E, Tatsis E, Paulsen J, Heller M, Nölle B, Gross WL: Maintenance of remission therapy in 65 patients with generalized Wegener's granulomatosis: Methotrexate versus trimethoprin-sulfamethoxazole [Abstract]. Sarcoidosis Vasculitis and Diffuse Lung Diseases 13: 276, 1996.
29. Hoffman GS, Leavitt RY, Kerr GS, Fauci AS: The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum 35: 1322-1329, 1992.
30. Cohen Tervaert JW, Stegeman CA, Kallenberg CGM: Serial ANCA testing is useful in monitoring disease activity of patents with ANCA-associated vasculitides. Sarcoidosis Vasculitis and Diffuse Lung Disease 13: 241-245, 1996.
31. DeOliveira J, Gaskin G, Dash A, Rees AJ, Pusey CD: Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis. Am J Kidney Dis 25: 380-389, 1995.